Nerve Regeneration in NYC: How Regenerative Medicine Is Changing the Treatment of Peripheral Neuropathy
Peripheral neuropathy — nerve damage resulting in numbness, tingling, burning, or weakness in the extremities — affects an estimated 20 million Americans. For decades, treatment has been largely symptomatic: gabapentin, duloxetine, and topical agents that reduce pain signals without addressing the underlying nerve damage. At Regen Health Physicians NYC (RHPNY), Dr. Ajit Dhaliwal takes a fundamentally different approach — applying regenerative medicine principles to support actual nerve repair.
Understanding Peripheral Neuropathy
The peripheral nervous system comprises all nerves outside the brain and spinal cord. These nerves carry sensory signals (touch, pain, temperature), motor signals (muscle control), and autonomic signals (organ function) between the body and central nervous system.
When peripheral nerves are damaged — by diabetes, chemotherapy, trauma, autoimmune disease, vitamin deficiency, or unknown causes — the resulting symptoms depend on which fibers are affected:
- Sensory neuropathy: Numbness, tingling, burning, hypersensitivity
- Motor neuropathy: Weakness, muscle wasting, coordination problems
- Autonomic neuropathy: Digestive issues, blood pressure instability, sweating abnormalities
Diabetic peripheral neuropathy (DPN) is the most common form, affecting 50% of diabetics over their lifetime.
Why Conventional Treatment Falls Short
Conventional neuropathy treatment targets the symptom (pain), not the nerve. Medications like gabapentin and pregabalin reduce neuronal excitability but do not:
- Promote myelin sheath repair
- Stimulate Schwann cell regeneration
- Improve endoneurial blood flow
- Address the metabolic or inflammatory drivers of ongoing damage
The result: patients manage symptoms for years while underlying nerve damage continues to progress.
Regenerative Approaches to Nerve Healing
PRP (Platelet-Rich Plasma)
PRP contains high concentrations of neurotrophic growth factors including NGF (nerve growth factor), BDNF (brain-derived neurotrophic factor), and VEGF (vascular endothelial growth factor). These signals are critical for:
- Schwann cell proliferation (Schwann cells form the myelin sheath that insulates peripheral nerves)
- Axonal sprouting and elongation
- Improved vascular supply to nerve tissue
Preclinical and early clinical studies have demonstrated that PRP injections along affected nerve pathways can reduce neuropathic pain scores and improve sensory function scores over 3–6 months.
Muse Stem Cell Therapy
RHPNY offers Muse stem cell therapy — an advanced regenerative technology using Multilineage-differentiating Stress Enduring (Muse) cells. Muse cells are naturally occurring pluripotent-like stem cells that can differentiate into neuronal and Schwann cell-like cells in damaged tissue environments.
Animal studies have shown Muse cells migrate to sites of nerve injury, reduce apoptosis of damaged neurons, and support functional recovery. RHPNY is among a select group of practices in the US making Muse cell therapy available for complex regenerative cases.
Peptide Therapy for Nerve Repair
Several peptides available at RHPNY have demonstrated neuroprotective and neuroregenerative properties:
- BPC-157: Promotes nerve regeneration in animal models — accelerates functional recovery after sciatic nerve crush injury
- Thymosin Beta-4: Promotes myelination and Schwann cell proliferation
- NAD+ precursors: Support mitochondrial function in neurons, which is critical for axonal integrity
Metabolic and Nutritional Optimization
For diabetic neuropathy, metabolic optimization is foundational:
- Glycemic control (reducing HbA1c below 6.5% slows progression)
- Alpha-lipoic acid (600–1800 mg/day has RCT evidence for DPN symptom reduction)
- Methylcobalamin (active B12 — critical for myelin synthesis)
- Benfotiamine (fat-soluble B1 — reduces advanced glycation products implicated in DPN)
At RHPNY, Dr. Dhaliwal evaluates nutritional status and metabolic function as part of every chronic disease consultation.
The RHPNY Neuropathy Evaluation
A comprehensive neuropathy evaluation at RHPNY includes:
- Detailed neurological examination
- Identification of etiology (diabetes, autoimmune, nutritional, toxic)
- Nerve conduction studies coordination if indicated
- Metabolic panel, HbA1c, B12, folate, inflammatory markers
- Assessment of candidacy for regenerative interventions
Treatment is then individualized — combining metabolic optimization, targeted nutritional support, and appropriate regenerative therapies based on neuropathy severity and etiology.
Book a consultation at RHPNY to explore whether regenerative medicine can support your nerve healing journey.
---
This content is for educational purposes only and does not constitute medical advice. All treatments at RHPNY are performed by Dr. Ajit Dhaliwal, MD, following a thorough clinical evaluation. Regenerative therapies for neuropathy are part of an emerging evidence base; individual outcomes vary significantly.
